Fortrea Holdings Inc. (FTRE) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 10/29/26
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug DevelopmentGlobeNewsWire • 10/22/26
Fortrea Holdings Inc. (FTRE) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 10/22/26
Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical TrialsGlobeNewsWire • 10/19/26
Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference CallGlobeNewsWire • 10/05/26
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 09/10/26
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical TrialsGlobeNewsWire • 09/02/26
Fortrea Holdings Inc. (FTRE) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 07/31/26
Fortrea Holdings Inc. (FTRE) Is Attractively Priced Despite Fast-paced MomentumZacks Investment Research • 07/31/26
Fortrea Holdings Inc. (FTRE) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/29/26
Top Healthcare Stocks Beyond The Market Rotation Averaging 128% Forward EPS GrowthSeeking Alpha • 07/24/26
Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the FirmBusiness Wire • 07/23/26